SecBot SecBot
8-K ·Filed Apr 7, 2026

IRD

Opus Genetics, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001140361-26-013481
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This filing is a routine executive compensation update. Traders should note it as a governance/retention measure but not a material event. Monitor for any subsequent M&A activity that could trigger these agreements.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
IRD ▼ -14.02% at T+60d
NEUTRAL call -14.02% · α vs SPY -27.29% · entry $4.92 → $4.23
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
+4.67%
call +4.67% · α +2.14%
$5.15
settled 7mo ago
T+5d
+12.80%
call +12.80% · α +7.48%
$5.55
settled 7mo ago
T+20d
+6.10%
call +6.10% · α -3.68%
$5.22
settled 6mo ago
T+60d
-14.02%
call -14.02% · α -27.29%
$4.23
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Opus Genetics entered into change in control bonus agreements with its four executive officers, including the CEO and CFO, to reimburse them for any excise taxes incurred under Section 4999 of the Internal Revenue Code in the event of a change in control. This is a standard retention and compensation measure for executives.

Key Facts

  • Agreements cover CEO Dr. George Magrath, CFO Robert Gagnon, COO Joseph Schachle, and CSO Dr. Ashwath Jayagopal.
  • Each executive will receive a gross-up payment covering any excise tax (and related income taxes on the gross-up) under Section 4999 if a change in control occurs.
  • An independent accounting firm (280G Firm) will determine the amount of any required gross-up payment.
  • The agreements are compensatory arrangements, not triggered by any current change in control event.

Financial Impact

Potential future liability dependent on a change in control event and resulting excise tax calculations; no immediate financial impact.

executive compensationpotential future tax liability

Risk Factors

  • Potential for significant cash outflow if a change in control occurs and excise taxes are triggered.
  • The gross-up provision could be viewed negatively by shareholders as excessive compensation in a takeover scenario.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-013481
Document: ef20069654_ex10-1.htm0001140361-26-013481
Document: 0001140361-26-013481-index-headers.html0001140361-26-013481
Document: 0001140361-26-013481-index.html0001140361-26-013481
Document: 0001140361-26-013481.txt0001140361-26-013481
27 reports for IRD
Performance horizon
50% Hit rate @ T+60 2 of 4 directional calls Went positive at some point 5 of 8 best @ T+60▲ +28.19%May 12, 2026
Filters
Rows
Reports for IRD — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 3/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 27, 2026
today
Insider Cluster
NEUTRAL ★ 2/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 23, 2026
4d ago
144
NEUTRAL ★ 2/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 21, 2026
6d ago
8-K
NEUTRAL ★ 2/10
$3.82awaiting T+60—$3.46 (−9.42%)
Oct 15, 2026
12d ago
8-K
BULLISH ★ 6/10
$3.84awaiting T+60—$3.46 (−9.90%)
Oct 15, 2026
12d ago
Press Release
BULLISH ★ 6/10
$3.84awaiting T+60—$3.46 (−9.90%)
Sep 22, 2026
5w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.16awaiting T+60—$3.46 (−32.95%)
Sep 11, 2026
6w ago
8-K
BULLISH ★ 7/10
$6.04awaiting T+60—$3.46 (−42.72%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.73awaiting T+60—$3.46 (−39.62%)
Sep 2, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$4.45awaiting T+60—$3.46 (−22.25%)
Showing 10 of 27

US Market Status

Market Closed — Opens Thu (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026